rs727505005
Positions:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001042545.2(LTBP4):c.1427-13C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
LTBP4
NM_001042545.2 intron
NM_001042545.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.67
Genes affected
LTBP4 (HGNC:6717): (latent transforming growth factor beta binding protein 4) The protein encoded by this gene binds transforming growth factor beta (TGFB) as it is secreted and targeted to the extracellular matrix. TGFB is biologically latent after secretion and insertion into the extracellular matrix, and sheds TGFB and other proteins upon activation. Defects in this gene may be a cause of cutis laxa and severe pulmonary, gastrointestinal, and urinary abnormalities. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LTBP4 | NM_001042545.2 | c.1427-13C>G | intron_variant | ENST00000396819.8 | NP_001036010.1 | |||
LTBP4 | NM_001042544.1 | c.1628-13C>G | intron_variant | NP_001036009.1 | ||||
LTBP4 | NM_003573.2 | c.1517-13C>G | intron_variant | NP_003564.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LTBP4 | ENST00000396819.8 | c.1427-13C>G | intron_variant | 1 | NM_001042545.2 | ENSP00000380031.5 | ||||
LTBP4 | ENST00000308370.11 | c.1628-13C>G | intron_variant | 1 | ENSP00000311905.8 | |||||
LTBP4 | ENST00000204005.13 | c.1517-13C>G | intron_variant | 1 | ENSP00000204005.10 | |||||
LTBP4 | ENST00000598717.5 | n.429-1857C>G | intron_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 14, 2014 | The 1628-13C>G variant in LTBP4 has not been reported in individuals with pulmon ary disease and data from large population studies is insufficient to assess the frequency of this variant. This variant is located in the 3' splice region. Com putational tools do suggest an impact to splicing. However, this information is not predictive enough to determine pathogenicity. In summary, additional informa tion is needed to fully assess the clinical significance of the 1628-13C>G varia nt. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at